Czech stock

PXCZK

Philip Morris CR

TABAK.PR

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

54/ 100

Overall score·TABAK.PR

Current price

17,780CZK

23/10/2026

P/E, P/B

Valuation

Neutral

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

Forward P/E 11,1 a dividendový výnos 6,2 % působí příznivě, zatímco P/B 7,4 a EV/EBITDA 12,2 valuaci částečně zvyšují; celkové ocenění je proto smíšené. Ziskovost a nízká beta jsou relativní silné stránky, ale slabý růst, vysoký poměr dluhu k vlastnímu kapitálu a cena pod 50denním i 200denním průměrem představují slabší dimenze.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 59%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Metrics summary

A quick look at Philip Morris CR (TABAK.PR) combining financial health, the short-term signal, valuation, DCF, management quality and operating metrics. It is analytical context, not a recommendation to buy or sell.

54/100

The overall score is based mainly on long-term fundamentals, complemented by the current signal and the available qualitative rating of the company.

52/100

Neutral signal based on current news, price action and the economy.

63/100

A lower score means the stock is expensive relative to the company's earnings and assets.

77% below fair value

An estimate of what the stock should be worth based on the company's future cash.

How fast the company's revenue grows year on year.

68/100

How much the company earns from each unit of revenue and from invested capital.

48/100

Debt level, share-price volatility and how resilient the company is in bad times.

65/100

AI estimate of management quality, execution and capital allocation.

75/100

AI estimate of the company's durable competitive advantage.

§ Context and events

Management

Fabio Acosta je předsedou představenstva a generálním ředitelem. Maurizio Lionetti vede finance, Dimitrios Karampis oblast lidí a kultury a Petr Sebek vnější vztahy. Strategicky je pro firmu podstatná kombinace tradičních tabákových výrobků s rozvojem bezdýmných alternativ, včetně IQOS, při současném řízení nákladů a regulatorních požadavků.

Articles about Philip Morris CR, in Czech (0)

No articles yet. New analyses are published daily.

§ Frequently asked questions

What is Philip Morris CR (TABAK.PR)?

Philip Morris CR (TABAK.PR) is a czech stock traded on PX. Sector: Consumer goods. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Philip Morris CR price today?

As of 23 October 2026, Philip Morris CR trades at about 17,780 CZK per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Philip Morris CR?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Philip Morris CR pay a dividend?

Philip Morris CR either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is Philip Morris CR a good investment in 2026?

Our AI signal currently rates Philip Morris CR as neutral (score 52/100). Financial health comes out at 54/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. The DCF model currently puts the price about 77 % below its model fair value. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More Czech stocks

Vienna Insurance Group

MONET.PRhealth 69/100

Kofola CeskoSlovensko

KOFOL.PRhealth 57/100

Photon Energy

PFN.PRhealth 39/100

§ How to buy Philip Morris CR

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Neutral

News summary

Older news

Signal 22/10, 20:02

Philip Morris s podnikatelem spustil vlastní linku na recyklaci cigaretových nedopalků; pokud se projekt rozšíří, může posílit udržitelnost, jeho finanční dopad ale není doložen.

Recyklační projekt je mírně pozitivní signál pro udržitelnost firmy. Krátkodobý výhled však oslabuje klesající trend, slabé momentum a pokles ceny za poslední měsíc.

Risks: Pokud se linka neosvědčí nebo pokles ceny a slabé momentum přetrvají, pozitivní dopad projektu může být zanedbatelný.

More about the signal

Recyklační projekt je mírně pozitivní signál pro udržitelnost firmy. Krátkodobý výhled však oslabuje klesající trend, slabé momentum a pokles ceny za poslední měsíc.

Risks: Pokud se linka neosvědčí nebo pokles ceny a slabé momentum přetrvají, pozitivní dopad projektu může být zanedbatelný.

Signal history· 2

05/1016:0162 · Slightly positive
Philip Morris ČR zůstává v neutrální zóně, nic zásadního se neděje ve zprávách; technika ukazuje mírný pozitivní vývoj se stabilním trendem.
29/0910:3031 · Slightly negative
Makro prostředí je méně příznivé pro tabákové firmy; cenový tlak a stabilita spotřeby mohou ovlivnit marže. Technika ukazuje mírný pokles, RSI blízko neutrálního stavu.

The full 90-day signal history is part of Premium.

Ask the AI

§ Model fair value (DCF)

Undervalued77% below fair value

78,746.08

range 61,874.4 – 103,267.2

Current price

17,780.00 CZK

23 Oct 26

PriceFair value range (DCF)UndervaluedOvervalued

What the calculation is based on

Model

78,746.08 CZK

range 61,874.4 CZK – 103,267.2 CZK

: 3.0%
: 8.0%
: 4,433.98 CZK

Růst FCF 3 % p.a. je konzervativní předpoklad pro zavedenou tabákovou společnost při stagnujících tržbách a poklesu EPS. Diskontní sazba 8 % zohledňuje nízkou betu, ale také regulatorní rizika odvětví; terminální růst 2 % odpovídá dlouhodobému růstu ekonomiky.

DCF terms explained+

DCF (discounted cash flow) estimates how much cash the company will generate in the future and converts it into today's value per share.

Free cash flow (FCF) is the money left after running the business and investing. “12 m” means the last 12 months.

The discount rate expresses risk: the riskier the company, the higher the rate and the lower the fair value.

Fair value is a model estimate — not the market price and not an investment recommendation.

With Premium you can adjust growth, the discount rate and free cash flow, and the fair value recalculates live.

Adjust assumptions14 days free →

A model estimate, not an investment recommendation. Past performance does not guarantee future results.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 17 of 18

Valuation score

4/ 6

4/6 tests available

1. Below DCF fair value

77.4% below the DCF midpoint.

2. Well below DCF value

Discount = below the range or at least 15% below the midpoint.

3. Price vs. the last year

3% above the 1-year low (17,700.0 CZK to 20,250.0 CZK), based on stored daily prices.

4. P/E vs. similar companies

P/E 16.8 vs. median 18.9 (18 companies).

5. P/E relative to growth

PEG or a reliable growth input is not available.

6. Analyst price target

A price target exists, but coverage is too low to count in the score.

Price vs DCF

Current price

17,780.0 CZK

Low 61,874.4 CZKHigh 103,267.2 CZK

Current priceDCF midpoint: 78,746.1 CZK

Price vs analyst target

Current price

17,780.0 CZK

Low 19,030.0 CZKHigh 19,527.0 CZK

Current priceAverage: 19,278.5 CZK

DCF gap

below range

77.4% below the DCF midpoint (78,746.1 CZK).

Analyst target

+8.4%

Average target 19,278.5 CZK vs. price 17,780.0 CZK.

Analyst consensus

Target range

19,030.0 CZK - 19,527.0 CZK

Coverage

2 analysts

Analyst consensus

Changes 180 d

+0 / -0

EPS next year

Revenue next year

Valuation multiples

16.8

11.1

7.4

2.3

12.2

52-week range3% above the low

17,700.0 CZK20,250.0 CZK

-7.0%

0.0%

13.4%

43.5%

Price vs 50D-3.9%

Price vs 200D-6.4%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 23/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

good

Vedení prosazuje rozvoj zahřívaných a dalších bezdýmných produktů vedle tradičních cigaret, což podporuje strategickou adaptaci, přestože výsledky zatím ukazují jen omezený růst.

strong

Silné zavedené značky, rozsah distribuce a zkušenosti v regulovaném odvětví tvoří významnou konkurenční výhodu, kterou oslabuje dlouhodobý ústup klasických cigaret.

Information

Type: Czech stock
Symbol: TABAK.PR
Exchange: PX
Currency: CZK
Sector: Consumer goods
: 16.8x
: 49.1B USD
: 10.8 %
: 0.13

§ Risk profile

Výsledky mohou negativně ovlivnit zvýšení spotřebních daní, přísnější regulace tabákových a nikotinových výrobků nebo rychlejší pokles prodeje cigaret. Českému investorovi navíc hrozí nižší likvidita akcie a koncentrace podnikání v regulovaném odvětví.

Ask the AI about Philip Morris CR All signals